Sign Out
Raloxifene is only for use in postmenopausal women.
Raloxifene must not be taken by women of childbearing potential. Raloxifene may cause foetal harm when administered to a pregnant woman. If this medicinal product is used mistakenly during pregnancy or the patient becomes pregnant while taking it, the patient should be informed of the potential hazard to the foetus.
It is not known whether raloxifene is excreted in human milk. Its clinical use, therefore, cannot be recommended in lactating women. Larfen may affect the development of the baby.
